Data as of Jan 30
| +0.08 / +2.07%|
The 5 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 14.00, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +255.33% increase from the last price of 3.94.
The current consensus among 6 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.